Virotherapy: best clinics abroad

Oncolytic virus therapy uses selected viruses to attack cancer cells and can also stimulate an immune response against a tumour. Its role depends on the specific product, cancer diagnosis and approved indication. It is not a universal treatment for cancer: some applications are established for narrowly defined situations, while many others remain under investigation in clinical trials.

An oncology review should confirm the tumour type, extent of disease, previous treatment and available standard options before a programme abroad is considered. Ask for the exact medicine or investigational product, its regulatory status in the destination country, evidence relevant to your diagnosis and the proposed monitoring plan. An offer described simply as virotherapy does not establish eligibility or benefit. Treatment may involve repeated visits, precautions around injection sites and coordination with other cancer care; neither response nor cure can be promised.

What the treatment involves

Oncolytic viruses are selected or modified to infect and damage tumour cells. Some treatments are injected directly into accessible tumours. The resulting cell damage can help the immune system recognise cancer, but this mechanism does not mean that every tumour will respond.

Indications and evidence

Talimogene laherparepvec, also called T-VEC, is an example used for selected patients with melanoma that has returned after surgery and cannot be removed surgically. This does not establish suitability for other cancers. Many virus-based strategies, combinations and delivery methods are experimental. The specific product and diagnosis must be assessed together, with alternatives discussed through an oncology consultation.

Preparation and treatment visits

Send pathology, staging scans and summaries of previous treatment before travelling. The team needs to review medicines, immune suppression, pregnancy considerations, infections and general health. For an injection-based programme, clinicians assess which lesions can be treated and explain the schedule, dressing care and reassessment. A clinical trial additionally requires formal eligibility checks and a clear explanation of its purpose and uncertainties.

Monitoring and risks

Side effects vary by product. With T-VEC, they can include fever, chills, fatigue, nausea and pain at an injection site. Infection and healing problems also require attention. Because this treatment uses a modified herpes virus, patients and caregivers receive precautions against accidental exposure. Immune suppression can change safety and eligibility. Follow the team's instructions about dressings, contact precautions and symptoms requiring urgent help.

Organising care abroad

Request a written account of the proposed treatment and its status rather than relying on a general label. Check whether the estimate includes assessment, medicine, repeat administration, laboratory monitoring, scans and management of complications. Agree how ongoing cancer care and information will be transferred to the home team if treatment ends or the disease progresses.

Frequently asked questions

Is virotherapy suitable for all cancers?

No. Evidence and eligibility are specific to the product, tumour and treatment setting.

Does trial participation guarantee access?

No. Screening, protocol criteria and available places determine whether participation is possible.

Can it replace my current treatment automatically?

No. Changes require an oncology decision considering standard options, disease control and the risks of interruption.

Oncology: treatment and diagnostics abroad

Conditions

• Adenocarcinoma
• Astrocytoma
• Basalioma
• Bladder cancer
• Bone cancer (osteosarcoma)
• Bowel cancer
• Brain Cancer
• Breast cancer
• Cervical cancer
• Chondrosarcoma
• Chordoma
• Colon cancer

Procedures and treatment

• Hysterectomy with DaVinci robot
• Intraarterial chemotherapy
• Arranging green laser
• Brachytherapy
• Breast cancer surgery (1)
• CAR T-cell therapy
• Chemotherapy
• Chimoembolization
• CyberKnife for lung cancer
• Da Vinci prostatectomy
• High intensity focused ultrasonic ablation (HIFU)
• Holmium Laser Enucleation of the Prostate

Diagnostics

• Scintigraphy
• 3D CT
• Abdominal MRI scan
• Biopsy
• Blood test for tumor markers
• BRAF gene mutation analysis
• Brain biopsy
• Check-up (basic)
• Check-up diagnostics (Gold program)
• Complex diagnostics of breast cancer
• Complex diagnostics of lung cancer
• Complex diagnostics of thyroid